Litcius/Paper detail

DHRS12 inhibits the proliferation and metastasis of osteosarcoma via Wnt3a/β-catenin pathway

Zhixian Xu, Wubing He, Tie Ke, Yongfa Zhang, Guifeng Zhang

2020Future Oncology15 citationsDOI

Abstract

Aim: This experimental design was based on DHRS12 to explore its biological effects on osteosarcoma (OS). Materials & methods: The expression level of endogenous DHRS12 was analyzed by immunohistochemical analysis. DHRS12 was overexpressed in MG-63 and HOS cells by plasmid transfection. Cell proliferation, invasion, migration, apoptosis and western blot were used in the experiment. Results: The expression of DHRS12 was significantly reduced in OS. Overexpression of DHRS12 inhibited the proliferation, migration and invasion of MG-63 and HOS cells and induced apoptosis of OS cells. Overexpression of DHRS12 upregulated Bax, Caspase 9 and Caspase 3. Overexpression of DHRS12 resulted in inactivation of the Wnt3a/β-catenin signaling pathway. Conclusion: Overexpression of DHRS12 inhibited the progression of OS via the Wnt3a/β-catenin pathway.

Topics & Concepts

CateninApoptosisCancer researchOsteosarcomaCell growthTransfectionDownregulation and upregulationWestern blotWnt signaling pathwayWNT3AImmunohistochemistryMetastasisBeta-cateninSignal transductionMedicineCell cultureBiologyCell biologyPathologyCancerInternal medicineGeneBiochemistryGeneticsCancer-related gene regulationWnt/β-catenin signaling in development and cancerProstate Cancer Treatment and Research
DHRS12 inhibits the proliferation and metastasis of osteosarcoma via Wnt3a/β-catenin pathway | Litcius